Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
NCT02107794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93
Last updated 2015-04-07
Summary
The investigators' decision aid for patients with GD, GD Choice, will be the result of a user-centered participatory action research involving) synthesis of the best available evidence from the literature and real-world registry experience, ii) input and involvement of patients, clinicians and other stakeholders, iii) direct observation of encounters and iv) extensive field-testing. The goal is to create a decision aid that will be rigorously evidence-based, clear and complete, able to be used by clinicians with minimal training time, while satisfying extant standards for rigorous high-quality shared decision making tools.
Conditions
- Graves' Disease
- Thyroid Disease
- Hyperthyroidism
Interventions
- OTHER
-
Decision Aid
Paper based decision aid will be utilized to facilitate treatment option conversation between clinician and patient.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Victor M Montori, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323 ·Status: RECRUITING ·Phase: PHASE2
-
Course for Brain Fatigue After Graves' Disease Controlled Study
NCT06134219 ·Status: RECRUITING ·Phase: NA
-
Graves' Disease Remission Study: MycoMeth Combo
NCT06068179 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole
NCT02727738 ·Status: COMPLETED ·Phase: NA
-
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
NCT06980103 ·Status: RECRUITING ·Phase: NA
-
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
NCT00004660 ·Status: COMPLETED ·Phase: NA
-
Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer
NCT06730893 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
NCT03066076 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
NCT07059507 ·Status: RECRUITING
-
Rituximab in the Treatment of Graves' Disease
NCT00150111 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT06727604 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
NCT03892993 ·Status: RECRUITING ·Phase: NA
-
Change of Gut Microbiome in the Treatment of Graves' Disease
NCT04383795 ·Status: COMPLETED
-
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
NCT05907668 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab (RTX) Therapy in Patients With Active TAO
NCT02378298 ·Status: COMPLETED ·Phase: PHASE4
-
Observation in the Treatment of Graves' Disease
NCT05043233 ·Status: UNKNOWN
-
Decision Aid and Thyroid Nodules Management
NCT05264857 ·Status: RECRUITING ·Phase: NA
-
Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
NCT00917241 ·Status: COMPLETED ·Phase: PHASE4
-
Remission Induction and Sustenance in Graves' Disease 2
NCT00796913 ·Status: COMPLETED ·Phase: NA
-
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients
NCT03276988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
NCT07261345 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Block-replacement Therapy During Radioiodine Therapy
NCT00150124 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
NCT07286006 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy
NCT03098225 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4